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Abstract: 
Objective: To determine frequency of sub-clinical hypothyroidism in chronic disease patients.  
Patients and Methods: A cross sectional study conducted through non-probability purposive sampling from March to 
September 2010 in the Department of nephrology at Jinnah Postgraduate Medical College (JPMC), Karachi. Total 158 
patients aged ≥18years with stage 3 to 5 chronic kidney who not on maintenance hemodialysis were included and patients 
with history of thyroid surgery, known thyroid disease and on treatment or neck radiation were excluded. Chronic kidney 
disease defined as lower glomerular filtration rate (stage III 30-59ml/min/1.73m2), stage IV (15-29 ml/min/1.73m2) and 
stage V (<15 ml/min/1.73m2). Sub-clinical hypothyroidism was defined as elevated thyroid stimulating hormone (TSH) level 
>4.05mIU/dl and normal thyroxine (T4) level (0.89-1.79ng/dl).  
Results: Mean age was 50.63 (range 19-85years), 76 (48%) were males and 82 (52%) were females. Sub-clinical 
hypothyroidism was found in 31 (20%) patients among patients with chronic kidney disease. Out of these, 16 patients (52%) 
were females and 15 (48%) were males (p=0.565). Most patients (52%) were aged between 45--59 years followed by 25% in 
≥60yr and 23 % in aged 18-44years (p=0.371). Among severity of CKD patients; sub-clinical hypothyroidism was found in 
38% in stage III CKD, 36% in stage IV CKD and 26% in stage V CKD (p=0.962). Among duration of CKD; sub-clinical 
hypothyroidism was found in 58% with less than 1year of CKD, followed by 39% between 1-2years and 03% of more than 2 
years of CKD (p=0.107). 
Conclusion: Sub-clinical hypothyroidism is a common problem among patients with CKD and found in 20% of patients. 
SCH found in younger age group 45--59years and in patients with stage III and IV CKD.   
Key Words: Sub-clinical hypothyroidism, Chronic Kidney Disease, Glomerular filtration rate 
Corresponding author: 
 Dr. Pooran Mal, 
Assistant Professor,  
Department of Nephrology,  
LUMHS Jamshoro Sindh,  
Pakistan 
Email: zulfikar229@hotmail.com 
 
Please cite this article in press as Pooran Mal et al , Applications Subclinical Hypothyridism in Patients with 
Chronic Kidney Disease Visiting at Tertiary Care Hospital, Karachi, Indo Am. J. P. Sci, 2017; 4(10). 
QR code 
 
 
IAJPS 2017, 4 (10), 3729-3732                     Pooran Mal et al                      ISSN 2349-7750 
 
w w w . i a j p s . c o m  
 
Page 3730 
 
INTRODUCTION:  
Sub-clinical hypothyroidism (SCH) is prevalent 
around 3-8% in population regardless of thyroid 
disorders. [1, 2] It has been observed that SCH is 
related to dyslipidemia and cardiovascular adverse 
events [3,4]. Chronic kidney disease (CKD) is 
common condition and is associated with increase 
the risk of cardiovascular disease with prevalence 
of 13.1% in western population [5], while 17.2% in 
India [6] and 12.5% in Pakistan. [7] The alteration 
in thyroid hormones accelerates as CKD progresses 
[8, 9]. Hypothyroidism causes decrease in renal 
blood flow, glomerular filtration rate; reduce 
sodium reabsorption and concentrating urine 
responsible for progression to CKD. [10] The 
former literature reported SCH to being increase 
from 7% to 18% with statistical significance [11]. 
There is limited local data of sub-clinical 
hypothyroidism in chronic kidney disease, so we 
conducted study to determine the frequency of sub-
clinical hypothyroidism in patients with chronic 
kidney disease. 
 
PATIENTS & METHODS:  
A cross sectional study conducted through non-
probability purposive sampling from March to 
September 2010 in the Department of nephrology 
at Jinnah Postgraduate Medical College (JPMC), 
Karachi. Total of 158 patients were included on the 
basis of prevalence of sub-clinical hypothyroidism 
in CKD patients. All patients aged ≥18years with 
stage 3 to 5 chronic kidney who not on 
maintenance hemodialysis were included while 
patients with history of thyroid surgery, known 
thyroid disease and on treatment or neck radiation 
were excluded. Chronic kidney disease was defined 
as glomerular filtration rate of <60ml/min/m2 for 
≥3 months, irrespective of cause. GFR calculated 
by Cockcroft’s Gaul’s formula (140-age x weight 
in kg/72 x serum creatinine, multiply by 0.85 if 
female). The staging of chronic disease done on the 
basis of eGFR level while the sub-clinical 
hypothyroidism as TSH >4.05mIU/dl and normal 
T4 level (0.89-1.79ng/dl). After taking informed 
written consent, patient’s data (age, gender, 
duration of CKD) was taken and patient weight 
was checked. After that blood sample was sent to 
laboratory for serum creatinine, TSH and T4 level. 
GFR was calculated by Cockcroft’s Gaul’s formula 
as mentioned above and staging of CKD were 
done. Sub-clinical hypothyroidism was labelled on 
the basis of TSH and T4 level. The data was 
analyzed in SPSS 16 and frequencies and 
percentages and mean ±SD was calculated, the chi 
square test was used to determine proportion of 
sub-clinical hypothyroidism in patients with CKD. 
Stratification was done with regard to age, gender, 
duration and stage of CKD while the p-value of 
≤0.05 was labeled as significant.  
 
RESULTS:  
A total of 158 patients with chronic kidney disease 
stage 3 to 5 were included in our study. Mean age 
was 51.62 (range 18-85years). Mean of other 
variables mentioned in table # 1. Out of 158 
patients 76 (48%) were males and 82 (52%) were 
females. Sub-clinical hypothyroidism was found in 
31 (20%) patients among patients with chronic 
kidney disease. Out of these, 16 patients (52%) 
were females and 15 (48%) were males (p=0.565). 
Most patients (52%) were aged between 45--59 
years followed by 25% in ≥60yr and 23 % in aged 
18--44years (p=0.371). Among severity of CKD 
patients; sub-clinical hypothyroidism was found in 
38% in stage III CKD, 36% in stage IV CKD and 
26% in stage V CKD (p=0.962). Among duration 
of CKD; sub-clinical hypothyroidism was found in 
58% with less than 1year of CKD, followed by 
39% between 1-2years and 03% of more than 2 
years of CKD (p=0.107). The results are presented 
in table 1-2 and figure 1. 
 
TABLE # 1 MEAN ±SD OF QUANTITATIVE VARIABLES 
Variables Minimum Maximum Mean SD 
Age (years) 18 85 51.62 14.118 
Weight (kg) 26 105 62.33 13.680 
CKD duration (months) 2 120 15.68 15.613 
T4 level (ng/dl) 0 6 1.29 0.677 
TSH level (mIU/dl) 0 50 3.69 6.308 
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TABLE # 2 FREQUENCY OF VARIABLES AND ASSOCIATION WITH SCH 
Variables Total Number Sub-clinical Hypothyroidism P value 
Age 
18-44years 
45-59years 
≥60years 
 
46 (29%) 
64 (41%) 
48 (30%) 
 
07 (23%) 
16 (52%) 
08 (25%) 
 
 
0.371 
Gender 
Male 
Female 
 
76 (48%) 
82 (52%) 
 
15 (48%) 
16 (52%) 
 
0.565 
CKD stage 
III 
IV 
V 
 
39 (24%) 
58 (37%) 
61 (39%) 
 
 
08 (26%) 
11 (36%) 
12 (38%) 
 
 
0.005 
Duration of CKD 
<1year 
1-2years 
>2years 
 
107 (68%) 
39 (25%) 
12 (07%) 
 
18 (58%) 
12 (39%) 
01 (03%) 
 
 
0.107 
Sub-clinical hypothyroidism 31 (20%)   
 
 
 
 
 
 
FIGURE 01: THE FREQUENCY OF SUBCLINICAL HYPOTHYROIDISM IN CKD 
DISCUSSION:  
We conducted study to determine the frequency of 
SCH among patients with chronic kidney disease at 
tertiary care hospital. In our study, SCH was found 
in 20% of CKD patients and this is comparable 
with study done by Chonchol et al in which SCH 
was found in 18% with GFR <60 ml/min [11. In 
our study most patients were females with SCH 
and most were younger age group. The risk of sub-
clinical hypothyroidism increase with progression 
of CKD and found 20.4% with stage III, 23% in 
stage IV and 23% in stage V CKD (P < 0.001), this 
comparable with our study in which 26% in stage 
III, 36% in stage IV and 38% in stage V CKD 
(p=<0.005) [12]. Former literature has mentioned 
higher prevalence for thyroid hormones 
abnormalities or goiter in individuals with chronic 
kidney diseases [13-17].  Few studies observed that 
abnormal level of thyroid hormone in subjects 
required hemodialysis are predictors for 
cardiovascular mortality [15-17], due to an 
association with underlying existence of chronic 
inflammatory process. Various contributing factors 
has been observed including altered metabolism of 
iodine, autoimmune thyroiditis and reduce 
peripheral sensitivity for thyroid hormones, but 
exact underlying process for such association 
remain unclear. The overt primary hypothyroidism 
(myxedema), common metabolic alteration 
reported is hyponatremia resulting from 
disturbance in kidney diluting function leads to 
water re-absorption [18]. Furthermore clinically 
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overt hypothyroidism also responsible for renal 
alterations in hemodynamic due to reduce cardiac 
output leads to progressive reduction in GFR. The 
future advance studies needs to be conducted in 
multidisciplinary manner to establish the link 
between chronic kidney disease and SCH and also 
to explore the associated cardiovascular and 
cerebrovascular adverse events. Thus, it has need to 
be sort further that the individuals with CKS should 
be explore for SCH at primary, secondary and 
tertiary care health units requires further 
multicentre research. 
 
CONCLUSION:  
Sub-clinical hypothyroidism is a common issue in 
subjects with CKD found in 20% patients. SCH 
found in younger age group 45--59years and 
patients with stage III and IV disease. Early 
detection of SCH in CKD may decrease the risk of 
cardiovascular events and progression of kidney 
disease. Our limitations include; small sample size, 
infrequent follow up and we did not focus on 
impact of SCH on progression of CKD, so need to 
conduct study at larger scale to detect the 
relationship of SCH with severity and progression 
of CKD.       
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